KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other financing activities (2016 - 2022)

Bristol Myers Squibb (BMY) has disclosed Other financing activities for 14 consecutive years, with $179.0 million as the latest value for Q4 2022.

  • On a quarterly basis, Other financing activities rose 6066.67% to $179.0 million in Q4 2022 year-over-year; TTM through Dec 2022 was $984.0 million, a 53.51% increase, with the full-year FY2023 number at $27.0 million, down 97.26% from a year prior.
  • Other financing activities was $179.0 million for Q4 2022 at Bristol Myers Squibb, up from $53.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $419.0 million in Q2 2022 to a low of -$58.0 million in Q1 2018.
  • A 5-year average of $103.0 million and a median of $35.5 million in 2020 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: plummeted 1400.0% in 2019, then skyrocketed 17200.0% in 2020.
  • Bristol Myers Squibb's Other financing activities stood at $1.0 million in 2018, then tumbled by 1400.0% to -$13.0 million in 2019, then soared by 2230.77% to $277.0 million in 2020, then plummeted by 101.08% to -$3.0 million in 2021, then skyrocketed by 6066.67% to $179.0 million in 2022.
  • Per Business Quant, the three most recent readings for BMY's Other financing activities are $179.0 million (Q4 2022), $53.0 million (Q3 2022), and $419.0 million (Q2 2022).